This website uses cookies to improve the site and user experience. By continuing to browse this site,
you agree to accept our use of cookies. For more information, please review our Cookies Policy
AMCP 2020
Presentations
Brentuximab Vedotin | Lymphoma | Abstract C35
Real-World Treatment Patterns and Overall Survival Among Medicare Fee-For-Service Beneficiaries Newly Diagnosed With Peripheral T-Cell Lymphoma